Efficacy, safety, and B-cell depletion capacity of three rituximab dosing regimens in the treatment of moderate-to-severe pemphigus vulgaris and pemphigus foliaceus: a 52-week clinical trial
{{output}}
Background: Rituximab (RTX) is effective for pemphigus, but optimal dosing remains uncertain. Objective: Compare efficacy, safety, and B-cell d... ...
